EDUCATION
OHIO NORTHERN UNIVERSITY COLLEGE OF LAW, Ada, Ohio. Juris Doctor 1997
Book Awards:
Regulation of Pharmaceuticals and Biotechnology
Contracts
Products Liability
Civil Procedure
Honors:
Law Review: Journal of Pharmacy and Law, Staff Editor;
Moot Court Board of Advocates, Burke E. Smith Mock Trial Competition, semi-finalist;
Judicial Scholarship 1994-1997;
Deans List 1997;
President of the International Law Society
Electives:
Regulation of Pharmaceuticals and Biotechnology; Patent Law; Intellectual Property.
UNIVERSITY OF TOLEDO, Toledo, Ohio. 2001.
Medicinal & Biological Chemistry Department, (Graduate coursework).
UNIVERSITY OF ARIZONA, Tucson, Arizona, Doctor of Philosophy [Ph.D.] 1993.
Pharmacy Administration (Major); Philosophy (Minor).
Graduate electives in the discovery, development, testing, marketing, regulation, and distribution of pharmaceuticals and new drug entities as well as the philosophy of science and biomedical ethics.
UNIVERSITY OF ARIZONA, Tucson, Arizona, Doctor of Pharmacy 1987.
Advanced courses and electives:
Biochemistry; Pharmaceutical and Medicinal Chemistry; Toxicology; Pharmacokinetics; Pharmacology; Advanced Therapeutics; Scientific Measurement and Instrumentation; and clinical research.
LEGAL EXPERIENCE
Rocky River, Ohio. February 2002 to present.
Founding Partner: Patent and Trademark preparation, prosecution and litigation.
HARNESS, DICKEY AND PIERCE, St. Louis, MO October 2001-February 2002.
Associate Patent Attorney: Responsibilities include national & international licensing, preparation and prosecution of patent applications in the arts of medicinal and pharmaceutical chemistry, and biotechnology.
Representative arts: Medicinal and Biological Chemistry.
MACMILLAN, SOBANSKI & TODD, Toledo, OH March 2000-October 2001
Associate Patent Attorney: Responsibilities include national & international licensing, preparation and prosecution of patent applications. Representative arts: Physical & Organic Chemistry, Material Sciences, Medical Devices
ERIE COUNTY PUBLIC DEFENDER AND LEGAL AID, Sandusky, OH 1998-March 2000 Staff Attorney: Conducted civil and felony criminal litigation, including pre-trial negotiations and discovery, client interview, legal research, hearing and motion practice. Concluded two jury trials to jury verdict.
HONORABLE ANN B. MASCHARI, SANDUSKY, Sandusky, OH 1997-1998
Erie County Court of Common Pleas, Staff Attorney. Duties included summary judgment research and ruling recommendations, pretrial and discovery dispute resolution, jury instructions, post-conviction relief.
PROFESSIONAL LICENSURE
Licensed to practice law in Ohio, District of Columbia, Michigan, District Court Northern Ohio - Western Division, Supreme Court of the United States, and before the United States Patent and Trademark Office. Licensed to practice pharmacy in Ohio and Arizona.
TEACHING EXPERIENCE: UNIVERSITY OF ARIZONA
Lectures and examination preparation for the College of Pharmacy: Methodology in Pharmacy Research and Drug Literature Evaluation, Psychosocial Aspects of Drug Use, Professional Practice Management, and Perspectives in Health Care.
PHARMACEUTICAL AND BIOTECHNOLOGY PATENT PROSECUTION EXPERIENCE
Patent 6,380,258 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds
Patent 6,362,183 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds
Patent 6,335,3363(5)-Heteroaryl substituted pyrazoles as p38 kinase inhibitors
3 (5)-Heteroaryl Substituted Pyrazoles As P38 Kinase Inhibitors (New Zealand)
Amidoaromatic Ring Sulfonamide Hydroxamic Acid Compounds
Aromatic Sulfone Hydroxamic Acid Metalloproteases Inhibitor
Aromatic Sulfonyl Alpha-Hydroxy Hydroxamic Acid Compounds
Canine Cdna Fragments Differentially Expressed In Osteoarthritis
Enhanced Pharmacokinetic Profile Of Intradermally Delivered Substances
N-Hydroxy 4-Sulfonyl Butanamide Compounds
Substituted Pyrazoles As P38 Kinase Inhibitors (Australia, Eurasia, Georgia, Russia, Singapore, Taiwan)
Sulfonyl Aryl Or Heteroaryl Hydroxamic Acid Compounds
Sulfonyl Divalent Aryl Or Heteroaryl Hydroxamic Acid
Systemin (European)
Thiol Sulfone Compounds
MECHANICAL PATENT PREPARATION AND PROSECUTION EXPERIENCE (UNITED STATES)
6,637,722 Hunnicutt October 28, 2003 Pilot operated microvalve device
6,627,146 McKibben, et al. September 30, 2003 Stopper module device for a casting machine furnace apparatus
6,619,119 Duggan , et al. September 16, 2003 Balance weight for vehicular driveshaft
6,581,673 McKibben , et al. June 24, 2003 Method for controlling the filling of a mold cavity of a casting machine
6,561,679 Erion, et al. May 13, 2003 Decorative coating for exterior automotive lighting applications
6,540,203 Hunnicutt April 1, 2003 Pilot operated microvalve device
6,536,258 Mostaghel March 25, 2003 Blast load simulation system
6,536,928 Hein, et al. March 25, 2003 Multi-colored vehicle interior lighting
6,505,671 McKibben, et al. January 14, 2003 Method for producing a sand core
6,502,672 McKibben, et al. January 7, 2003 Brake for a rotary turntable
6,494,804 Hunnicutt, et al. December 17, 2002 Microvalve for electronically controlled transmission
6,464,753 Horne, et al. October 15, 2002 Furnace flue dust processing method
6,446,877 Gaines, et al. September 10, 2002 Gas fired humidifier
6,406,662 Molnar, et al. June 18, 2002 Rotary hearth furnace with charge slot air shield
6,390,810 Rinker, et al. May 21, 2002 Method and apparatus for reducing a feed material in a rotary hearth furnace
6,357,465 Caldwell, et al. March 19, 2002 Shipping cap for evacuation valve
6,298,607 Mostaghel, et al. October 9, 2001Venting-membrane system to mitigate blast effects
6,395,060 Horne, et al. May 28, 2002 Furnace flue dust processing method
PHARMACY PRACTICE EXPERIENCE
1987-2003 Practicing pharmacist for hospital in-patient, Health Maintenance Organization, and community pharmacy settings.
PHARMACY CONSULTANT EXPERIENCE
Pharmaceutical management and clinical consultant to the State of Arizona Department of Economic Security, Sierra Tucson Hospital and Drug Rehabilitation Center, several geriatric long-term care facilities in Tucson, Arizona, and Charter Hospital of Tucson.
PUBLICATIONS
"PerSeptive Biosystems v. Pharmacia Biotech Inc." The Journal of Biolaw and Business, Summer/Fall 2001.
American Intellectual Property Law Association, Chemical Practice Committee, Judicial and Administrative Decision Subcommittee Report, "Terms That Do Not Occur In a Patent's Claims Can Nonetheless Be Read Into Claims." January 2001.
American Intellectual Property Law Association, Chemical Practice Committee, Judicial and Administrative Decision Subcommittee Report, "No Subject Matter Jurisdiction Over Claims not Asserted by Plaintiff." October 2000.
American Intellectual Property Law Association, Chemical Practice Committee, Judicial and Administrative Decision Subcommittee Report, "Issue Preclusion Results in Claim Construction from One Litigation being Applied in Another Litigation; Doctrine of Equivalents Cannot be used to Reclaim Surrendered Rights." October 2000.
Evaluation of a Bioethics Committee Intervention: A Limitation of Medical Treatment Form. HEC Forum, May/June 96, vol. 86, no. 3.
Consequences of End-of-Life Physician Orders: Economic and Hospital Policy Implications. Dissertation Abstracts, 1993.
Moral development: Results of Rest's defining issues test. Am. J. Pharm. Educ., 1992; 56:140-144.
The theoretical base of pharmacy. Am. J. Hosp. Pharm., 1991; 48:536-540.
Evaluation of lithium-tetracycline interaction. Clinical Pharmacy, 1988; 7:314-317.
PRESENTATIONS
Obviousness in Patent Law Trap for the unwary Presented at Inventors Connection of Greater Cleveland, May 2004
Inventorship: Who gets put on. Presented at Cleveland Intellectual Property Association, March 4, 2003
Consequences of a Limitation of Medical Treatment Policy. Presented at University of Montana College of Pharmacy, Missoula, Montana; March 25, 1993; Chicago College of Pharmacy, Downers Grove, Illinois; April 10, 1993; University Medical Center Hospital Bioethics Committee, Tucson, Arizona; April 26, 1993.
The Prerogative to Discontinue Medical Treatment Policy. Presented at American College of Legal Medicine Annual Meeting, Anaheim, California; March 20, 1994.
Human Subjects Considerations in Clinical Research. Presented at University of Arizona College of Pharmacy, Tucson, Arizona; March 23, 1994.
|
|
